PATENT CLAIM ANALYSIS

Application Number: 16225989
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["714", "001000"]

Abstract:
The disclosure relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotide molecules comprising an mRNA encoding an OX40L polypeptide. Also provided is a method for activating T cells or increasing the number of NK cells in a subject in need thereof.

Claim (Index 29):
The method of  claim 23 , wherein the mRNA comprises a 5\u2032 UTR comprising the nucleotide sequence as set forth in SEQ ID NO: 27, and a 3\u2032 UTR comprising the nucleotide sequence as set forth in SEQ ID NO: 63.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 98.0
- Lexical Diversity: 1.225
- Patent Class: 714.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16207575', '15996140', '15995889', '16184282', '16222155']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.4873906785271227
- 35 USC 102 Novelty (BERT): 0.6745292714917326
- Combined Prediction Score: 0.5061045378235838
- Mean Citation Score: 667.4214380000002
- Max Citation Score: 764.2173
- Similarity Product: 665.2019861772717

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test